# PET Imaging to Delineate Macrophage Activation in Diabetic Gastroparesis

> **NCT04762719** · PHASE2,PHASE3 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 12 (actual)

## Conditions studied

- Diabetes
- Gastroparesis With Diabetes Mellitus

## Interventions

- **DRUG:** PET/CT Scan with 11C-ER176
- **DIAGNOSTIC_TEST:** Core biopsy of gastric muscle

## Key facts

- **NCT ID:** NCT04762719
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-10
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-03-31
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2023-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04762719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04762719, "PET Imaging to Delineate Macrophage Activation in Diabetic Gastroparesis". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT04762719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*